PerkinElmer Inc.

Symbol: PKI     Sector: Healthcare     Industry: Medical Diagnostics & Research

Dividend Yield
0.29%
Current Price
$95.18
Info     Dividend Rate History     Earnings     Financials     Rankings

Financials 2019

Update: 2019-06-10 13:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 1

2019-03-31
648,737,000
648,737,000
340,931,000
307,806,000
246,837,000
60,969,000
35,412,000
1,247,646,000
6,086,497,000
3,448,025,000
-
137,456,000
13,334,000
134,252,000
1,862,269,000
-29,309,000
-5,316,000
 
47,980,000

Financials 2018

Update: 2019-06-10 13:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
756,349,000
756,349,000
380,099,000
376,250,000
262,509,000
113,741,000
71,292,000
1,234,634,000
5,975,522,000
3,390,567,000
2,584,955,000
166,315,000
14,856,000
163,111,000
1,891,480,000
14,193,000
159,419,000
 
51,970,000

Q 3

2018-09-30
674,313,000
674,313,000
341,986,000
332,327,000
245,617,000
86,710,000
76,548,000
1,165,495,000
5,862,355,000
3,289,886,000
2,572,469,000
152,717,000
20,072,000
149,513,000
1,902,574,000
-7,820,000
93,192,000
 
48,848,000

Q 2

2018-06-30
703,362,000
703,362,000
363,222,000
340,140,000
252,076,000
88,064,000
64,063,000
1,202,413,000
5,957,778,000
3,440,601,000
2,517,177,000
163,596,000
17,315,000
163,392,000
2,001,268,000
-9,208,000
72,985,000
 
47,196,000

Q 1

2018-03-31
643,972,000
643,972,000
351,750,000
292,222,000
245,709,000
46,513,000
26,024,000
1,234,004,000
6,126,186,000
3,570,934,000
2,555,252,000
181,005,000
217,751,000
180,800,000
2,077,449,000
-25,216,000
-14,558,000
 
45,984,000

Financials 2017

Update: 2019-06-10 13:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
641,630,000
641,630,000
334,924,000
306,706,000
204,198,000
102,508,000
-41,117,000
1,199,955,000
6,091,463,000
3,588,275,000
2,503,188,000
202,134,000
217,306,000
202,134,000
2,006,109,000
-491,894,000
128,096,000
 
37,673,000